Robert A. Forbes

3.4k total citations · 1 hit paper
51 papers, 2.5k citations indexed

About

Robert A. Forbes is a scholar working on Psychiatry and Mental health, Pharmacology and Molecular Biology. According to data from OpenAlex, Robert A. Forbes has authored 51 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Psychiatry and Mental health, 13 papers in Pharmacology and 9 papers in Molecular Biology. Recurrent topics in Robert A. Forbes's work include Schizophrenia research and treatment (24 papers), Bipolar Disorder and Treatment (13 papers) and Treatment of Major Depression (12 papers). Robert A. Forbes is often cited by papers focused on Schizophrenia research and treatment (24 papers), Bipolar Disorder and Treatment (13 papers) and Treatment of Major Depression (12 papers). Robert A. Forbes collaborates with scholars based in United States, Germany and Japan. Robert A. Forbes's co-authors include Ajay Verma, Huasheng Lu, Robert D. McQuade, Elizabeth Murphy, Charles Steenbergen, William H. Carson, Tetsuro Kikuchi, Yoshihiro Tadori, Na Jin and Gregory A. Stephenson and has published in prestigious journals such as Journal of Biological Chemistry, Circulation Research and American Journal of Psychiatry.

In The Last Decade

Robert A. Forbes

51 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hypoxia-inducible Factor 1 Activation by Aerobic Glycolysis Implicates the Warburg Effect in Carcinogenesis

2002 691 citations Huasheng Lu, Robert A. Forbes et al. Journal of Biological Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert A. Forbes United States	21	999	742	461	287	254	51	2.5k
Markus Mitterhauser Austria	39	490 0.5×	828 1.1×	296 0.6×	75 0.3×	207 0.8×	258	5.0k
Sang Eun Kim South Korea	36	583 0.6×	510 0.7×	113 0.2×	145 0.5×	58 0.2×	162	3.4k
Jörgen Bergman Finland	38	543 0.5×	556 0.7×	184 0.4×	146 0.5×	190 0.7×	79	4.3k
Pertti Lehikoinen Finland	34	378 0.4×	712 1.0×	264 0.6×	68 0.2×	153 0.6×	72	3.6k
Elena Garcı́a-Martı́n Spain	41	365 0.4×	1.4k 1.8×	156 0.3×	307 1.1×	52 0.2×	239	5.5k
John Hilton United States	31	381 0.4×	1.2k 1.7×	188 0.4×	144 0.5×	81 0.3×	64	3.6k
Tetsuro Kikuchi Japan	35	1.8k 1.8×	1.7k 2.3×	128 0.3×	69 0.2×	288 1.1×	105	5.2k
Tsu‐Kung Lin Taiwan	39	435 0.4×	2.4k 3.2×	385 0.8×	187 0.7×	31 0.1×	162	5.1k
Carol L. Szumlanski United States	19	647 0.6×	1.1k 1.4×	49 0.1×	129 0.4×	309 1.2×	26	4.0k
Jean‐Paul Boissel France	24	359 0.4×	780 1.1×	131 0.3×	85 0.3×	113 0.4×	55	2.6k

Countries citing papers authored by Robert A. Forbes

Since Specialization

Citations

This map shows the geographic impact of Robert A. Forbes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Forbes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Forbes more than expected).

Fields of papers citing papers by Robert A. Forbes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Forbes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Forbes. The network helps show where Robert A. Forbes may publish in the future.

Co-authorship network of co-authors of Robert A. Forbes

This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. Forbes. A scholar is included among the top collaborators of Robert A. Forbes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. Forbes. Robert A. Forbes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Coffman, Jon, et al.. (2021). The design basis for the integrated and continuous biomanufacturing framework. Biotechnology and Bioengineering. 118(9). 3323–3333. 19 indexed citations

Wong, Dean F., Patricia Bricmont, James Robert Brašić, et al.. (2020). An open-label, positron emission tomography study of the striatal D2/D3 receptor occupancy and pharmacokinetics of single-dose oral brexpiprazole in healthy participants. European Journal of Clinical Pharmacology. 77(5). 717–725. 16 indexed citations

Forbes, Robert A., et al.. (2014). Stereoselective high-performance liquid chromatography and analytical method characterization of evacetrapib using a brush-type chiral stationary phase: A challenging isomeric separation requiring a unique eluent system. Journal of Chromatography A. 1363. 183–190. 6 indexed citations

Youngstrom, Eric A., Joan Zhao, Raymond Mankoski, et al.. (2013). Clinical Significance of Treatment Effects with Aripiprazole versus Placebo in a Study of Manic or Mixed Episodes Associated with Pediatric Bipolar I Disorder. Journal of Child and Adolescent Psychopharmacology. 23(2). 72–79. 21 indexed citations

Mankoski, Raymond, et al.. (2013). Aripiprazole Treatment of Irritability Associated with Autistic Disorder and the Relationship Between Prior Antipsychotic Exposure, Adverse Events, and Weight Change. Journal of Child and Adolescent Psychopharmacology. 23(8). 572–576. 25 indexed citations

Findling, Robert L., Christoph U. Correll, Margaretta Nyilas, et al.. (2013). Aripiprazole for the treatment of pediatric bipolar I disorder: a 30‐week, randomized, placebo‐controlled study. Bipolar Disorders. 15(2). 138–149. 48 indexed citations

Kalsekar, Iftekhar, et al.. (2012). Comparison of health-related quality of life among patients using atypical antipsychotics for treatment of depression: results from the National Health and Wellness Survey. Health and Quality of Life Outcomes. 10(1). 81–81. 11 indexed citations

Muzina, David J., et al.. (2011). Adjunctive aripiprazole for depression: predictive value of early assessment.. PubMed. 17(12). 793–801. 10 indexed citations

Mankoski, Raymond, et al.. (2011). Young Mania Rating Scale Line Item Analysis in Pediatric Subjects with Bipolar I Disorder Treated with Aripiprazole in a Short-Term, Double-Blind, Randomized Study. Journal of Child and Adolescent Psychopharmacology. 21(4). 359–364. 9 indexed citations

10.

Broder, Michael S., John A. Bates, Yonghua Jing, et al.. (2011). Association between second-generation antipsychotic medication half-life and hospitalization in the community treatment of adult schizophrenia. Journal of Medical Economics. 15(1). 105–111. 10 indexed citations

11.

McIntyre, Roger S., Susan L. McElroy, James M. Eudicone, et al.. (2011). A 52-Week, Double-Blind Evaluation of the Metabolic Effects of Aripiprazole and Lithium in Bipolar I Disorder. The Primary Care Companion For CNS Disorders. 13(6). 22 indexed citations

12.

Jing, Yonghua, Iftekhar Kalsekar, Suellen M. Curkendall, et al.. (2011). Intent-to-Treat Analysis of Health Care Expenditures of Patients Treated With Atypical Antipsychotics as Adjunctive Therapy in Depression. Clinical Therapeutics. 33(9). 1246–1257. 9 indexed citations

13.

Tadori, Yoshihiro, Robert A. Forbes, Robert D. McQuade, & Tetsuro Kikuchi. (2011). Functional potencies of dopamine agonists and antagonists at human dopamine D2 and D3 receptors. European Journal of Pharmacology. 666(1-3). 43–52. 57 indexed citations

14.

Fava, Maurizio, Christina Dording, Ross A. Baker, et al.. (2011). Effects of Adjunctive Aripiprazole on Sexual Functioning in Patients With Major Depressive Disorder and an Inadequate Response to Standard Antidepressant Monotherapy. The Primary Care Companion For CNS Disorders. 13(1). 17 indexed citations

15.

Robb, Adelaide S., William H. Carson, Margaretta Nyilas, et al.. (2010). Changes in Positive and Negative Syndrome Scale–Derived Hostility Factor in Adolescents with Schizophrenia Treated with Aripiprazole: Post Hoc Analysis of Randomized Clinical Trial Data. Journal of Child and Adolescent Psychopharmacology. 20(1). 33–38. 12 indexed citations

16.

Tadori, Yoshihiro, Robert A. Forbes, Robert D. McQuade, & Tetsuro Kikuchi. (2009). Receptor reserve-dependent properties of antipsychotics at human dopamine D2 receptors. European Journal of Pharmacology. 607(1-3). 35–40. 32 indexed citations

17.

Findling, Robert L., Margaretta Nyilas, Robert A. Forbes, et al.. (2009). Acute Treatment of Pediatric Bipolar I Disorder, Manic or Mixed Episode, With Aripiprazole. The Journal of Clinical Psychiatry. 70(10). 1441–1451. 140 indexed citations

18.

Lu, Huasheng, Robert A. Forbes, & Ajay Verma. (2002). Hypoxia-inducible Factor 1 Activation by Aerobic Glycolysis Implicates the Warburg Effect in Carcinogenesis. Journal of Biological Chemistry. 277(26). 23111–23115. 691 indexed citations breakdown →

19.

Petranka, John G., Gary L. Wright, Robert A. Forbes, & Elizabeth Murphy. (2001). Elevated Calcium in Preneoplastic Cells Activates NF-κB and Confers Resistance to Apoptosis. Journal of Biological Chemistry. 276(40). 37102–37108. 20 indexed citations

20.

Kirkby, R. Duncan, Robert A. Forbes, & Swaminathan Subramaniam. (1996). Modification of kainate-induced behavioral and electrographic seizures following inhibition of nitric oxide synthase in mice. Epilepsy Research. 24(2). 79–90. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact